ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 585,86
-0,61%
Dow Jones
40 211,72
0,53%
DAX
18 511,59
-0,48%
Brent Oil
83,675
-0,79%
Bitcoin
62 842,80
-3,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
06/03/201914h25GlobeNewswire Inc.Investor Expectations to Drive Momentum within Amarin, PulteGroup, LivaNova, Teva Pharmaceutical Industries, Viad, and Activi...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/201922h08Business WireTeva Announces Launch of an Authorized Generic of Flector® Patch (diclofenac epolamine topical patch) in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201902h50Dow Jones NewsTeva, FTC Reach Tentative Settlement in Low-Cost Generics Lawsuits -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201901h47Dow Jones NewsTeva, FTC Reach Tentative Settlement in Low-Cost Generics LawsuitsNYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201900h24Business WireTeva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the PartiesNYSE:TEVATeva Pharmaceutical Industries Ltd
19/02/201914h39Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/02/201913h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
14/02/201909h02Dow Jones NewsGenerics Maker Teva Turns Toward Biotech -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201917h51Dow Jones NewsTeva Shares Fall Sharply on 2018 Misses, Light 2019 TargetsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201914h54Dow Jones NewsKing of Generics Pushes Into Biotech DrugsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201913h00Business WireTeva Reports Fourth Quarter and Full Year 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201917h13Business WireTeva Announces U.S. Launch of a Generic Version of Sabril® (Vigabatrin)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201900h57Business WireTeva Announces Launch of ALYQ™ (Tadalafil Tablets USP), a Generic Version of ADCIRCA® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201920h33Dow Jones NewsAmgen, Eli Lilly Migraine Drugs to Be Covered by UnitedHealth Unit -ReutersNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201912h50Business WireTeva Receives Positive Committee for Medicinal Products for Human Use (CHMP) Opinion for AJOVY® (fremanezumab) for the Proph...NYSE:TEVATeva Pharmaceutical Industries Ltd
16/01/201919h50Dow Jones NewsFDA Approves Teva's Generic Version of Epilepsy DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
14/01/201922h00Business WireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results at 8 a.m. ET on February 13, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/201918h45Business WireTeva to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
03/01/201902h28Business WireTeva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl ProductNYSE:TEVATeva Pharmaceutical Industries Ltd
27/12/201818h05Business WireTeva Announces US Launch of a Generic Version of Elidel® (Pimecrolimus) Cream, 1%NYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201817h06Business WireADDING MULTIMEDIA Teva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/12/201822h39Dow Jones NewsFDA Approves Teva's Digital Asthma Inhaler With Built-In SensorsNYSE:TEVATeva Pharmaceutical Industries Ltd
21/12/201821h19Business WireTeva Announces FDA Approval of First & Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfat...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/12/201822h09Dow Jones NewsFTC Approves Teva Petition to Give Pfizer More Time to Sell DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
17/12/201814h00Business WireTeva Announces Positive Topline Phase IIIb Results with Fremanezumab in Adults with Migraine Who Did Not Respond to Multiple ...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/12/201800h31Business WireCelltrion & Teva Announce FDA Approval of HERZUMA® (trastuzumab-pkrb), a Biosimilar to HERCEPTIN®, for the Treatment of HER...NYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201823h57Dow Jones NewsFDA Approves Herceptin Biosimilar HerzumaNYSE:TEVATeva Pharmaceutical Industries Ltd
12/12/201816h33Dow Jones NewsFDA Issues Warning Letter to Zhejiang Huahai in Valsartan RecallNYSE:TEVATeva Pharmaceutical Industries Ltd
28/11/201821h38Business WireCelltrion & Teva Announce FDA Approval of TRUXIMA® (rituximab-abbs), a Biosimilar to RITUXAN®, for Three Non-Hodgkin’s Ly...NYSE:TEVATeva Pharmaceutical Industries Ltd
27/11/201818h08Dow Jones NewsTeva Releases Generic EpiPen in Limited Doses in the U.S. -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

LSE
XLFS
Inv Us Financia
LSE
SUSW
Wld Sri Eur Acc
LSE
RTYS
Inv Russel 2000
NYSE
NMD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés